Access cutting-edge hair loss treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access hair loss specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hair loss treatment provided free
This study will evaluate the safety and efficacy of VDPHL01 in female subjects with Androgenetic Alopecia (AGA). AGA is a genetic disorder caused by an excessive (too much) hair follicle response to androgens (hormones) that causes hair loss. VDPHL01 is an investigational oral drug to treat AGA. This multi-center, double blind, study will last about 13 months and includes 11 study visits (screening, baseline (day 1), week 2, month 1, month 2, month 4, month 6, month 8, month 10, month 12, mont
Sponsor: Veradermics, Inc.
Check if you qualify for this hair loss clinical trial in Phoenix, AZ
If you're searching for hair loss treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hair loss specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.